ReviewBMJ (Clinical research ed.)2018
Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in
Review in BMJ (Clinical research ed.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 9 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
105 citing papers in PubMed, 9 syntheses or guidelines pooled it.
- Faster but Not Truer, Part 2: The Regulatory Record, the Economics, and the TRACE-HEOR Reporting Standard.Journal of health economics and outcomes research · 2026Pooled it
- The lymphatic filariasis treatment study landscape: A systematic review of study characteristics and the case for an individual participant data platform.PLoS neglected tropical diseases · 2024Pooled it
- Prevalence and predictors of data and code sharing in the medical and health sciences: systematic review with meta-analysis of individual participant data.BMJ (Clinical research ed.) · 2023Pooled it
- New horizons in evidence-based care for older people: individual participant data meta-analysis.Age and ageing · 2022Pooled it
- Quality Reporting of Systematic Review and Meta-Analysis According to PRISMA 2020 Guidelines: Results from Recently Published Papers in theKorean journal of radiology · 2022Pooled it
- Systematic review of the status of veterinary epidemiological research in two species regarding the FAIR guiding principles.BMC veterinary research · 2021Pooled it
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.BMJ (Clinical research ed.) · 2021Guideline
- Cerebroplacental ratio in predicting adverse perinatal outcome: a meta-analysis of individual participant data.BJOG : an international journal of obstetrics and gynaecology · 2021Pooled it
- Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses.BMJ (Clinical research ed.) · 2020Pooled it
- Evaluation of methodology, reporting and transparency of 50 highly cited randomised trials in neurology: a cross-sectional analysis.BMJ open · 2026Article
- Evaluating the reproducibility and verifiability of nutrition research: a case study of studies assessing the relationship between potatoes and colorectal cancer.Nutrition & diabetes · 2026Review
- Improving machine-learning development in allergology: bridging the gap between open-access and cohort-based databases.Current opinion in allergy and clinical immunology · 2026Review
- Article
- Success rates of American clinical oncology trials by geographic factors.Scientific reports · 2026Article
- Cumulative gonadal hormone exposure is nonlinearly associated with risk of canine cranial cruciate ligament disease: a generalised additive model analysis of 20,590 dogs (1988-2023).The Journal of small animal practice · 2026Article
- Longitudinal dataset of journal data sharing policies across 22 disciplines for 2014 2019 and 2023.Scientific data · 2025Article
- Protecting patient privacy in tabular synthetic health data: a regulatory perspective.NPJ digital medicine · 2025Review
- Improving statistical reporting in psychology.Communications psychology · 2025Review
- Secondary Analysis of Randomized Controlled Trials: Methodological Considerations and Best Practices.Annals of clinical epidemiology · 2025Article
- A consensus privacy metrics framework for synthetic data.Patterns (New York, N.Y.) · 2025Article
45 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo explore the effectiveness of data sharing by randomized controlled trials (RCTs) in journals with a full data sharing policy and to describe potential difficulties encountered in the process of performing reanalyses of the primary outcomes.
designSurvey of published RCTs.
settingPubMed/Medline. ELIGIBILITY CRITERIA: RCTs that had been submitted and published by
main outcome measureThe primary outcome was data availability, defined as the eventual receipt of complete data with clear labelling. Primary outcomes were reanalyzed to assess to what extent studies were reproduced. Difficulties encountered were described.
results37 RCTs (21 from
conclusionsData availability was not optimal in two journals with a strong policy for data sharing. When investigators shared data, most reanalyses largely reproduced the original results. Data sharing practices need to become more widespread and streamlined to allow meaningful reanalyses and reuse of data.
trial registrationOpen Science Framework osf.io/c4zke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.